Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: A 24-week, open-label, prospective switch study in different settings in Taiwan

Authors
Category Primary study
JournalNeuropsychiatric Disease and Treatment
Year 2018
This article has no abstract
Epistemonikos ID: 1ccf821380c042a4c8181c762c74ff29292cb5af
First added on: Feb 09, 2025